
    
      The aim of this study was to evaluate the efficacy and safety of ACT combined with BAL for
      bronchiectasis patients with acute exacerbation through the whole study process, which will
      provide a high quality of evidence-based strategies for the treatment, revision and
      optimization of international and domestic clinical guidelines for bronchiectasis. All the
      participants will be required to check the various efficacy and safety indicators.
    
  